$ARAV Aravive, Inc. Insider Trading
Get free email notifications about insider trading in Aravive, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Aravive, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Aravive, Inc. for free.
CIK Number: 0001513818
IRS Number: 264106690
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: ARAV
Company Address: RIVER OAKS TOWER 3730 KIRBY DRIVE, SUITE 1200 HOUSTON 77098
Phone number: 6509638580
Former name: Versartis, Inc., date of change: 2011-02-23
Market Capitalization: $474.95M
Prev close: $13.30
Average Daily Volume: 112,481
Days Low: $12.80
Year Low: $6.17
Year High: $16.55
Aravive, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2021 | ARAV | Aravive, Inc. | Giaccia Amato | Director | Option Exercise | M | 0.06 | 4,028 | 242 | 0 | |
Mar 22 2021 | ARAV | Aravive, Inc. | Giaccia Amato | Director | Option Exercise | M | 0.06 | 8,055 | 483 | 0 | |
Mar 22 2021 | ARAV | Aravive, Inc. | Giaccia Amato | Director | Gift | G | 0.00 | 12,083 | 0 | 941,880 | 954 K to 941.9 K (-1.27 %) |
Mar 22 2021 | ARAV | Aravive, Inc. | Giaccia Amato | Director | Buy | M | 0.06 | 4,028 | 242 | 953,963 | 949.9 K to 954 K (+0.42 %) |
Mar 22 2021 | ARAV | Aravive, Inc. | Giaccia Amato | Director | Buy | M | 0.06 | 8,055 | 483 | 949,935 | 941.9 K to 949.9 K (+0.86 %) |
Jan 26 2021 | ARAV | Aravive, Inc. | Rangwala Reshma | Chief Medical Offic ... | Option Exercise | A | 5.95 | 10,000 | 59,500 | 10,000 | |
Jan 26 2021 | ARAV | Aravive, Inc. | McIntyre Gail Frances | CEO and President | Option Exercise | A | 5.95 | 165,000 | 981,750 | 165,000 | |
Jan 26 2021 | ARAV | Aravive, Inc. | Shah Vinay | Chief Financial Off ... | Option Exercise | A | 5.95 | 60,000 | 357,000 | 60,000 | |
Sep 29 2020 | ARAV | Aravive, Inc. | Rangwala Reshma | Chief Medical Offic ... | Option Exercise | A | 4.95 | 75,000 | 371,250 | 75,000 | |
Sep 17 2020 | ARAV | Aravive, Inc. | ROGERS MICHAEL W | Director | Option Exercise | A | 5.99 | 14,987 | 89,772 | 14,987 | |
Sep 17 2020 | ARAV | Aravive, Inc. | ROGERS MICHAEL W | Director | Option Exercise | A | 5.99 | 15,024 | 89,994 | 15,024 | |
Sep 15 2020 | ARAV | Aravive, Inc. | ESHELMAN FREDRIC N | Director | Option Exercise | A | 5.63 | 16,029 | 90,243 | 16,029 | |
Sep 15 2020 | ARAV | Aravive, Inc. | Tabibiazar Raymond | Director | Option Exercise | A | 5.63 | 16,029 | 90,243 | 16,029 | |
Sep 15 2020 | ARAV | Aravive, Inc. | Giaccia Amato | Director | Option Exercise | A | 5.63 | 16,029 | 90,243 | 16,029 | |
Sep 15 2020 | ARAV | Aravive, Inc. | Zhang Eric | Director | Option Exercise | A | 5.63 | 16,029 | 90,243 | 16,029 |